[ad_1] Dr Reddy’s Laboratories has announced a nationwide recall of one batch of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) in the US due to a labeling error on the infusion bag. The recall, which applies to lot number A1540076, was initiated after the infusion bag was incorrectly labeled as Levetiracetam in 0.82% […]
Dr Reddy’s sells 14-drug portfolio to Senores Pharma for US market expansion – CNBC TV18
[ad_1] Dr Reddy’s Laboratories Ltd has entered into an agreement with Ahmedabad-based Senores Pharmaceuticals Ltd to sell a portfolio of 14 Abbreviated New Drug Applications (ANDAs) for an undisclosed amount, Senores Pharma said in a press release on Tuesday. The acquired portfolio consists of 13 ANDAs already approved by the US Food and Drug Administration […]
Dr Reddy’s Labs gets VAI classification for Andhra Pradesh facility from USFDA – CNBC TV18
[ad_1] Dr Reddy’s Laboratories Ltd on Friday, September 6, announced that it has received an Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh. The inspection has been classified as “Voluntary Action Indicated” (VAI) by the US drug regulator, meaning that while some […]